Search for: "Sanofi US Corporation" Results 1 - 20 of 102
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2012, 4:56 pm by Guest Author for TradeSecretsLaw.com
  To those ends, in August 2006, when Sanofi hired Li as a medicinal chemist (later promoting her to a research scientist), it required Li to sign a “Conflict of Interest” statement, a certificate acknowledging her receipt of Sanofi’s corporate ethics and code of business conduct, an Inventions Agreement, and a document entitled “Trade Secrets and Confidential Information. [read post]
15 Mar 2016, 9:00 am by Suzette Pringle
On March 4, 2016, the Second Circuit affirmed the dismissal of two related securities actions against Sanofi Pharmaceuticals, its predecessor Genzyme Corporation, and three company executives (collectively, “Sanofi”). [read post]
18 Dec 2014, 4:43 pm
At the time, Sanofi operated under a corporate integrity agreement with the U.S. government mandating that it obey U.S. laws and report illegal activity. [read post]
15 Mar 2016, 5:09 pm by Kevin LaCroix
  Background   The multiple sclerosis drug Lemtrada was developed and owned by defendant Genzyme Corporation and, following a 2011 acquisition, Sanofi. [read post]
14 Mar 2014, 1:02 pm
The individual filed suit in Cook County Circuit Court against Bristol-Myers Squibb Co., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
14 Dec 2023, 10:00 pm by Chijioke Okorie
August: In Nigeria, the French multinational pharmaceutical and healthcare company Sanofi S.A., filed a petition with the Corporate Affairs Commission (CAC) in 2019, alleging that the registration of Sanofi Integrated Services Limited, Sanofi Nigeria Enterprises Limited, and Sanofi Nigerian Enterprise was unlawful. [read post]
18 Dec 2017, 5:57 pm by Dennis Crouch
by Dennis Crouch My former bosses Paul Berghoff and Alison Baldwin (at MBHB) won an interesting case today on behalf of Genzyme and its corporate parent Sanofi-Aventis. [read post]
26 Jul 2014, 9:14 pm by Mark Summerfield
  Methods of medical treatment came under scrutiny of the US Supreme Court in Mayo Collaborative Services v Prometheus Laboratories, Inc and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (see High Court Rules Methods of Medical Treatment Patent-Eligible). [read post]
4 Sep 2015, 6:02 pm by Ben Vernia
According to DOJ’s press release: Genzyme Corporation, a wholly-owned biotechnology subsidiary of French pharmaceutical company Sanofi, agreed today to resolve criminal charges that it violated the federal Food, Drug and Cosmetic Act (FDCA) with regard to the unlawful distribution of Seprafilm, a surgical device it markets and promotes, the Justice Department announced. [read post]
5 Oct 2020, 10:25 am by Dennis Crouch
Arthrex, Inc., No. 19-1452; Sanofi-Aventis Deutschland GmbH v. [read post]
15 Oct 2008, 8:38 am
In turn, consumers can no longer use the state protections when harmed by negligence or misconduct, giving total immunity to corporations instead.AAJ has tracked how the administration's first attempts to preempt states rights utilized friend-of-the-court briefs on behalf of corporations in civil justice cases. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 10/29: Aventis Pharma S.A. and Sanofi-Aventis US, LLC v. [read post]
9 Mar 2009, 4:44 am
They also got to use the corporate jet, and so did their wives.The largesse came despite the fact that Merck's sales declined 3 percent from $6.2 billion to $6 billion, and the company's stock fell by 50 percent, from $60.55 to $30.40. [read post]
16 Dec 2009, 2:51 pm by Sheppard Mullin
Very few neurokinin 1 receptor antagonists are in development in the U.S. market for the same uses as Emend. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/21: Aventis Pharama S.A., Sanofi-Aventis US LLC v. [read post]